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Abstract
Neisseria adhesin A (NadA) is present on the meningococcal surface and contributes to
adhesion to and invasion of human cells. NadA is also one of three recombinant antigens in
the recently-approved Bexsero vaccine, which protects against serogroup B meningococ-
cus. The amount of NadA on the bacterial surface is of direct relevance in the constant bat-
tle of host-pathogen interactions: it influences the ability of the pathogen to engage human
cell surface-exposed receptors and, conversely, the bacterial susceptibility to the antibody-
mediated immune response. It is therefore important to understand the mechanisms which
regulate nadA expression levels, which are predominantly controlled by the transcriptional
regulator NadR (Neisseria adhesin A Regulator) both in vitro and in vivo. NadR binds the
nadA promoter and represses gene transcription. In the presence of 4-hydroxyphenylace-
tate (4-HPA), a catabolite present in human saliva both under physiological conditions and
during bacterial infection, the binding of NadR to the nadA promoter is attenuated and nadA
expression is induced. NadR also mediates ligand-dependent regulation of many other
meningococcal genes, for example the highly-conserved multiple adhesin family (maf)
genes, which encode proteins emerging with important roles in host-pathogen interactions,
immune evasion and niche adaptation. To gain insights into the regulation of NadR medi-
ated by 4-HPA, we combined structural, biochemical, and mutagenesis studies. In particu-
lar, two new crystal structures of ligand-free and ligand-bound NadR revealed (i) the
molecular basis of ‘conformational selection’ by which a single molecule of 4-HPA binds
and stabilizes dimeric NadR in a conformation unsuitable for DNA-binding, (ii) molecular
explanations for the binding specificities of different hydroxyphenylacetate ligands, includ-
ing 3Cl,4-HPA which is produced during inflammation, (iii) the presence of a leucine residue
essential for dimerization and conserved in many MarR family proteins, and (iv) four resi-
dues (His7, Ser9, Asn11 and Phe25), which are involved in binding 4-HPA, and were
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confirmed in vitro to have key roles in the regulatory mechanism in bacteria. Overall, this
study deepens our molecular understanding of the sophisticated regulatory mechanisms of
the expression of nadA and other genes governed by NadR, dependent on interactions with
niche-specific signal molecules that may play important roles during meningococcal
pathogenesis.
Author Summary
Serogroup B meningococcus (MenB) causes fatal sepsis and invasive meningococcal dis-
ease, particularly in young children and adolescents, as highlighted by recent MenB out-
breaks in universities of the United States and Canada. The Bexsero vaccine protects
against MenB and has recently been approved in> 35 countries worldwide. Neisseria
adhesin A (NadA) present on the meningococcal surface can mediate binding to human
cells and is one of the three MenB vaccine protein antigens. The amount of NadA exposed
on the meningococcal surface also influences the antibody-mediated serum bactericidal
response measured in vitro. A deep understanding of nadA expression is therefore impor-
tant, otherwise the contribution of NadA to vaccine-induced protection against meningo-
coccal meningitis may be underestimated. The abundance of surface-exposed NadA is
regulated by the ligand-responsive transcriptional repressor NadR. Here, we present func-
tional, biochemical and high-resolution structural data on NadR. Our studies provide
detailed insights into how small molecule ligands, such as hydroxyphenylacetate deriva-
tives, found in relevant host niches, modulate the structure and activity of NadR, by ‘con-
formational selection’ of inactive forms. These findings shed light on the regulation of
NadR, a key MarR-family virulence factor of this important human pathogen.
Introduction
The ‘Reverse Vaccinology’ approach was pioneered to identify antigens for a protein-based
vaccine against serogroup B Neisseria meningitidis (MenB), a human pathogen causing poten-
tially-fatal sepsis and invasive meningococcal disease [1]. Indeed, Reverse Vaccinology identi-
fied Neisseria adhesin A (NadA), a surface-exposed protein involved in epithelial cell invasion
and found in ~30% of clinical isolates [2–4]. Recently, we reported the crystal structure of
NadA, providing insights into its biological and immunological functions [5]. Recombinant
NadA elicits a strong bactericidal immune response and is therefore included in the Bexsero
vaccine that protects against MenB and which was recently approved in over 35 countries
worldwide [6].
Previous studies revealed that nadA expression levels are mainly regulated by the Neisseria
adhesin A Regulator (NadR) [7]. Although additional factors influence nadA expression, we
focused on its regulation by NadR, the major mediator of NadA phase variable expression [8,
9]. Studies of NadR also have broader implications, since a genome-wide analysis of MenB
wild-type and nadR knock-out strains revealed that NadR influences the regulation of> 30
genes, includingmaf genes, from the multiple adhesin family [10]. These genes encode a wide
variety of proteins connected to many biological processes contributing to bacterial survival,
adaptation in the host niche, colonization and invasion [11, 12].
NadR belongs to the MarR (Multiple Antibiotic Resistance Regulator) family, a group of
ligand-responsive transcriptional regulators ubiquitous in bacteria and archaea. MarR family
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proteins can promote bacterial survival in the presence of antibiotics, toxic chemicals, organic
solvents or reactive oxygen species [13, 14] and can regulate virulence factor expression [15].
MarR homologues can act either as transcriptional repressors or as activators [16].
Although> 50 MarR family structures are known, a molecular understanding of their ligand-
dependent regulatory mechanisms is still limited, often hampered by lack of identification of
their ligands and/or DNA targets. A potentially interesting exception comes from the ligand-
free and salicylate-bound forms of theMethanobacterium thermoautotrophicum protein
MTH313 which revealed that two salicylate molecules bind to one MTH313 dimer and induce
large conformational changes, apparently sufficient to prevent DNA binding [17]. However,
the homologous archeal Sulfolobus tokodaii protein ST1710 presented essentially the same
structure in ligand-free and salicylate-bound forms, apparently contrasting the mechanism
proposed for MTH313 [18]. Despite these apparent differences, MTH313 and ST1710 bind
salicylate in approximately the same site, between their dimerization and DNA-binding
domains. However, it is unknown whether salicylate is a relevant in vivo ligand of either of
these two proteins, which share ~20% sequence identity with NadR, rendering unclear the
interpretation of these findings in relation to the regulatory mechanisms of NadR or other
MarR family proteins [16].
NadR binds the nadA promoter and represses gene transcription [9]. NadR binds nadA on
three different operators (OpI, OpII and OpIII) [10]. The DNA-binding activity of NadR is
attenuated in vitro upon addition of various hydroxyphenylacetate (HPA) derivatives, includ-
ing 4-HPA. 4-HPA is a small molecule derived from mammalian aromatic amino acid catabo-
lism and is released in human saliva, where it has been detected at micromolar concentration
[19]. In the presence of 4-HPA, NadR is unable to bind the nadA promoter and nadA gene
expression is induced [9, 10]. In vivo, the presence of 4-HPA in the host niche of N.meningiti-
dis serves as an inducer of NadA production, thereby promoting bacterial adhesion to host
cells [10]. Further, we recently reported that 3Cl,4-HPA, produced during inflammation, is
another inducer of nadA expression [20].
Extending our previous studies based on hydrogen-deuterium exchange mass spectrometry
(HDX-MS) [21], here we sought to reveal the molecular mechanisms and effects of NadR/HPA
interactions via X-ray crystallography, NMR spectroscopy and complementary biochemical
and in vivomutagenesis studies. We obtained detailed new insights into ligand specificity, how
the ligand allosterically influences the DNA-binding ability of NadR, and the regulation of
nadA expression, thus also providing a deeper structural understanding of the ligand-respon-
sive MarR super-family. Moreover, these findings are important because the activity of NadR
impacts the potential coverage provided by anti-NadA antibodies elicited by the Bexsero vac-
cine and influences host-bacteria interactions that contribute to meningococcal pathogenesis
[20].
Results
NadR is dimeric and is stabilized by specific hydroxyphenylacetate
ligands
Recombinant NadR was produced in E. coli using an expression construct prepared from N.
meningitidis serogroup B strain MC58. Standard chromatographic techniques were used to
obtain a highly purified sample of NadR (seeMaterials and Methods). In analytical size-exclu-
sion high-performance liquid chromatography (SE-HPLC) experiments coupled with multi-
angle laser light scattering (MALLS), NadR presented a single species with an absolute molecu-
lar mass of 35 kDa (S1 Fig). These data showed that NadR was dimeric in solution, since the
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theoretical molecular mass of the NadR dimer is 33.73 kDa; and, there was no change in oligo-
meric state on addition of 4-HPA.
The thermal stability of NadR was examined using differential scanning calorimetry (DSC).
Since ligand-binding often increases protein stability, we also investigated the effect of various
HPAs (Fig 1A) on the melting temperature (Tm) of NadR. As a control of specificity, we also
tested salicylate, a known ligand of some MarR proteins previously reported to increase the Tm
of ST1710 and MTH313 [17]. The Tm of NadR was 67.4 ± 0.1°C in the absence of ligand, and
was unaffected by salicylate. However, an increased thermal stability was induced by 4-HPA
and, to a lesser extent, by 3-HPA. Interestingly, NadR displayed the greatest Tm increase upon
addition of 3Cl,4-HPA (Table 1 and Fig 1B).
NadR displays distinct binding affinities for hydroxyphenylacetate
ligands
To further investigate the binding of HPAs to NadR, we used surface plasmon resonance
(SPR). The SPR sensorgrams revealed very fast association and dissociation events, typical of
small molecule ligands, thus prohibiting a detailed study of binding kinetics. However, steady-
Fig 1. Stability of NadR is increased by small molecule ligands. (A)Molecular structures of 3-HPA (MW 152.2), 4-HPA (MW 152.2), 3Cl,4-HPA (MW
186.6) and salicylic acid (MW 160.1). (B) DSC profiles, colored as follows: apo-NadR (violet), NadR+salicylate (red), NadR+3-HPA (green), NadR+4-HPA
(blue), NadR+3Cl,4-HPA (pink). All DSC profiles are representative of triplicate experiments.
doi:10.1371/journal.ppat.1005557.g001
Table 1. Melting-point (Tm) and its ligand-induced increase (ΔTm) derived from DSC thermostability
experiments. Dissociation constants (KD) of the NadR/ligand interactions from SPR steady-state binding
experiments.
Ligand Tm (°C) ΔTm (°C) KD (mM)
No ligand 67.4 ± 0.1 n.a. n.a.
Salicylate 67.5 ± 0.1 0 n.d.
3-HPA 70.0 ± 0.1 2.7 2.7 ± 0.1
4-HPA 70.7 ± 0.1 3.3 1.5 ± 0.1
3Cl,4-HPA 71.3 ± 0.2 3.9 1.1 ± 0.1
n.a.: not applicable; n.d.: not determinable
doi:10.1371/journal.ppat.1005557.t001
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state SPR analyses of the NadR-HPA interactions allowed determination of the equilibrium
dissociation constants (KD) (Table 1 and S2 Fig). The interactions of 4-HPA and 3Cl,4-HPA
with NadR exhibited KD values of 1.5 mM and 1.1 mM, respectively. 3-HPA showed a weaker
interaction, with a KD of 2.7 mM, while salicylate showed only a very weak response that did
not reach saturation, indicating a non-specific interaction with NadR. A ranking of these KD
values showed that 3Cl,4-HPA was the tightest binder, and thus matched the ranking of
ligand-induced Tm increases observed in the DSC experiments. Although these KD values indi-
cate rather weak interactions, they are similar to the values reported previously for the MarR/
salicylate interaction (KD ~1 mM) [22] and the MTH313/salicylate interaction (KD 2–3 mM)
[17], and approximately 20-fold tighter than the ST1710/salicylate interaction (KD ~20 mM)
[18].
Crystal structures of holo-NadR and apo-NadR
To fully characterize the NadR/HPA interactions, we sought to determine crystal structures of
NadR in ligand-bound (holo) and ligand-free (apo) forms. First, we crystallized NadR (a sele-
nomethionine-labelled derivative) in the presence of a 200-fold molar excess of 4-HPA. The
structure of the NadR/4-HPA complex was determined at 2.3 Å resolution using a combination
of the single-wavelength anomalous dispersion (SAD) and molecular replacement (MR) meth-
ods, and was refined to Rwork/Rfree values of 20.9/26.0% (Table 2). Despite numerous attempts,
we were unable to obtain high-quality crystals of NadR complexed with 3Cl,4-HPA, 3,4-HPA,
3-HPA or DNA targets. However, it was eventually possible to crystallize apo-NadR, and the
structure was determined at 2.7 Å resolution by MR methods using the NadR/4-HPA complex
as the search model. The apo-NadR structure was refined to Rwork/Rfree values of 19.1/26.8%
(Table 2).
The asymmetric unit of the NadR/4-HPA crystals (holo-NadR) contained one NadR homo-
dimer, while the apo-NadR crystals contained two homodimers. In the apo-NadR crystals, the
two homodimers were related by a rotation of ~90°; the observed association of the two dimers
was presumably merely an effect of crystal packing, since the interface between the two homo-
dimers is small (< 550 Å2 of buried surface area), and is not predicted to be physiologically rel-
evant by the PISA software [23]. Moreover, our SE-HPLC/MALLS analyses (see above)
revealed that in solution NadR is dimeric, and previous studies using native mass spectrometry
(MS) revealed dimers, not tetramers [21].
The NadR homodimer bound to 4-HPA has a dimerization interface mostly involving the
top of its ‘triangular’ form, while the two DNA-binding domains are located at the base (Fig
2A). High-quality electron density maps allowed clear identification of the bound ligand,
4-HPA (Fig 2B). The overall structure of NadR shows dimensions of ~50 × 65 × 50 Å and a
large homodimer interface that buries a total surface area of ~ 4800 Å2. Each NadR monomer
consists of six α-helices and two short β-strands, with helices α1, α5, and α6 forming the dimer
interface. Helices α3 and α4 form a helix-turn-helix motif, followed by the “wing motif” com-
prised of two short antiparallel β-strands (β1-β2) linked by a relatively long and flexible loop.
Interestingly, in the α4-β2 region, the stretch of residues from R64-R91 presents seven posi-
tively-charged side chains, all available for potential interactions with DNA. Together, these
structural elements constitute the winged helix-turn-helix (wHTH) DNA-binding domain
and, together with the dimeric organization, are the hallmarks of MarR family structures [16].
A single conserved leucine residue (L130) is crucial for dimerization
The NadR dimer interface is formed by at least 32 residues, which establish numerous inter-
chain salt bridges or hydrogen bonds, and many hydrophobic packing interactions (Fig 3A and
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3B). To determine which residues were most important for dimerization, we studied the inter-
face in silico and identified several residues as potential mediators of key stabilizing interac-
tions. Using site-directed mutagenesis, a panel of eight mutant NadR proteins was prepared
(including mutations H7A, S9A, N11A, D112A, R114A, Y115A, K126A, L130K and L133K),
sufficient to explore the entire dimer interface. Each mutant NadR protein was purified, and
then its oligomeric state was examined by analytical SE-HPLC. Almost all the mutants showed
the same elution profile as the wild-type (WT) NadR protein. Only the L130K mutation
Table 2. Data collection and refinement statistics for NadR structures.
NadR SeMet + 4-HPA (SAD peak) (PDB code 5aip) NadR apo-form (PDB code 5aiq)
Data collection
Wavelength (Å) 0.9792 1.0
Beamline SLS (PXII-X10SA) SLS (PXII-X10SA)
Resolution range (Å) 39.2–2.3 48.2–2.7
Space group P 43 21 2 P 43 21 2
Unit cell dimensions (Å) 75.3, 75.3, 91.8 69.4, 69.4, 253.8
Total reﬂections 291132 (41090) 225521 (35809)
Unique reﬂections 12320 (1773) 17700 (2780)
Multiplicity 23.6 (23.2) 12.7 (12.8)
Completeness (%) 100.0 (100.00) 99.9 (99.7)
Mean I/sigma(I) 25.5 (9.0) 22.6 (3.8)
Wilson B-factor 23.9 49.1
Rsym* 10.9 (39.4) 11.4 (77.6)
Rmeas** 11.3 11.8
Reﬁnement
Rwork
] 20.9 21.7
Rfree
]] 26.0 27.2
Number of atoms
Non-hydrogen atoms 2263 4163
Macromolecules 2207 4144
Ligands 11 0
Water 45 19
Protein residues 275 521
RMS(bonds) 0.008 0.003
RMS(angles) 1.09 0.823
Ramachandran (%)§
Favored 100 98.4
Outliers 0 0
Clash score 5.0 3.9
Average B-factor
Macromolecules 34.8 53.3
Ligands 32.9 -
Solvent 37.3 (H2O) 29.0 (H2O)
Statistics for the highest-resolution shell are shown in parentheses.
*Rsym = Σhkl Σi |Ii(hkl)—<I(hkl)>| / Σhkl Σi Ii(hkl)
** Rmeas = redundancy-independent (multiplicity-weighted) Rmerge as reported from AIMLESS [43].
] Rwork = Σ||F(obs)|- |F(calc)||/Σ|F(obs)|
]] Rfree = as for Rwork, calculated for 5.0% of the total reﬂections, chosen at random, and omitted from reﬁnement.
§ Values obtained using Molprobity [41].
doi:10.1371/journal.ppat.1005557.t002
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induced a notable change in the oligomeric state of NadR (Fig 3C). Further, in SE-MALLS
analyses, the L130K mutant displayed two distinct species in solution, approximately 80%
being monomeric (a 19 kDa species), and only 20% retaining the typical native dimeric state (a
35 kDa species) (Fig 3D), demonstrating that Leu130 is crucial for stable dimerization. It is
notable that L130 is usually present as Leu, or an alternative bulky hydrophobic amino acid
(e.g. Phe, Val), in many MarR family proteins, suggesting a conserved role in stabilizing the
dimer interface. In contrast, most of the other residues identified in the NadR dimer interface
were poorly conserved in the MarR family.
The holo-NadR structure presents only one occupied ligand-binding
pocket
The NadR/4-HPA structure revealed the ligand-binding site nestled between the dimerization
and DNA-binding domains (Fig 2). The ligand showed a different position and orientation
compared to salicylate complexed with MTH313 and ST1710 [17, 18] (see Discussion). The
binding pocket was almost entirely filled by 4-HPA and one water molecule, although there
also remained a small tunnel 2-4Å in diameter and 5-6Å long leading from the pocket (proxi-
mal to the 4-hydroxyl position) to the protein surface. The tunnel was lined with rather hydro-
phobic amino acids, and did not contain water molecules. Unexpectedly, only one monomer of
the holo-NadR homodimer contained 4-HPA in the binding pocket, whereas the correspond-
ing pocket of the other monomer was unoccupied by ligand, despite the large excess of 4-HPA
used in the crystallization conditions.
Inspection of the protein-ligand interaction network revealed no bonds from NadR back-
bone groups to the ligand, but several key side chain mediated hydrogen (H)-bonds and ionic
interactions, most notably between the carboxylate group of 4-HPA and Ser9 of chain A
(SerA9), and chain B residues TrpB39, ArgB43 and TyrB115 (Fig 4A). At the other ‘end’ of the
ligand, the 4-hydroxyl group was proximal to AspB36, with which it may establish an H-bond
(see bond distances in Table 3). The water molecule observed in the pocket was bound by the
carboxylate group and the side chains of SerA9 and AsnA11.
In addition to the H-bonds involving the carboxylate and hydroxyl groups of 4-HPA, bind-
ing of the phenyl moiety appeared to be stabilized by several van der Waals’ contacts, particu-
larly those involving the hydrophobic side chain atoms of LeuB21, MetB22, PheB25, LeuB29
and ValB111 (Fig 4A). Notably, the phenyl ring of PheB25 was positioned parallel to the
Fig 2. The crystal structure of NadR in complex with 4-HPA. (A) The holo-NadR homodimer is depicted in
green and blue for chains A and B respectively, while yellow sticks depict the 4-HPA ligand (labelled). For
simplicity, secondary structure elements are labelled for chain B only. Red dashes show hypothetical
positions of chain B residues 88–90 that were not modeled due to lack of electron density. (B) A zoom into the
pocket occupied by 4-HPA shows that the ligand contacts both chains A and B; blue mesh shows electron
density around 4-HPA calculated from a composite omit map (omitting 4-HPA), using phenix [38]. The map is
contoured at 1σ and the figure was prepared with a density mesh carve factor of 1.7, using Pymol (www.
pymol.org).
doi:10.1371/journal.ppat.1005557.g002
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phenyl ring of 4-HPA, potentially forming π-π parallel-displaced stacking interactions. Conse-
quently, residues in the 4-HPA binding pocket are mostly contributed by NadR chain B, and
effectively created a polar ‘floor’ and a hydrophobic ‘ceiling’, which house the ligand. Collec-
tively, this mixed network of polar and hydrophobic interactions endows NadR with a strong
recognition pattern for HPAs, with additional medium-range interactions potentially estab-
lished with the hydroxyl group at the 4-position.
Structure-activity relationships: molecular basis of enhanced
stabilization by 3Cl,4-HPA
Wemodelled the binding of other HPAs by in silico superposition onto 4-HPA in the holo-
NadR structure, and thereby obtained molecular explanations for the binding specificities of
Fig 3. Analysis of the NadR dimer interface. (A) Both orientations show chain A, green backbone ribbon, colored red to highlight all locations involved in
dimerization; namely, inter-chain salt bridges or hydrogen bonds involving Q4, S5, K6, H7, S9, I10, N11, I15, Q16, R18, D36, R43, A46, Q59, C61, Y104,
D112, R114, Y115, D116, E119, K126, E136, E141, N145, and the hydrophobic packing interactions involving I10, I12, L14, I15, R18, Y115, I118, L130,
L133, L134 and L137. Chain B, grey surface, is marked blue to highlight residues probed by site-directed mutagenesis (E136 only makes a salt bridge with
K126, therefore it was sufficient to make the K126Amutation to assess the importance of this ionic interaction; the H7 position is labelled for monomer A,
since electron density was lacking for monomer B). (B) A zoom into the environment of helix α6 to show how residue L130 chain B (blue side chain) is a focus
of hydrophobic packing interactions with L130, L133, L134 and L137 of chain A (red side chains). (C) SE-HPLC analyses of all mutant forms of NadR are
compared with the wild-type (WT) protein. TheWT and most of the mutants show a single elution peak with an absorbance maximum at 17.5 min. Only the
mutation L130K has a noteworthy effect on the oligomeric state, inducing a second peak with a longer retention time and a second peak maximum at 18.6
min. To a much lesser extent, the L133K mutation also appears to induce a ‘shoulder’ to the main peak, suggesting very weak ability to disrupt the dimer. (D)
SE-HPLC/MALLS analyses of the L130K mutant, shows 20% dimer and 80%monomer. The curves plotted correspond to Absorbance Units (mAU) at
280nmwavelength (green), light scattering (red), and refractive index (blue).
doi:10.1371/journal.ppat.1005557.g003
Molecular Basis of NadR Regulation
PLOS Pathogens | DOI:10.1371/journal.ppat.1005557 April 22, 2016 8 / 25
diverse ligands. For example, similar to 4-HPA, the binding of 3Cl,4-HPA could involve multi-
ple bonds towards the carboxylate group of the ligand and some to the 4-hydroxyl group. Addi-
tionally, the side chains of LeuB29 and AspB36 would be only 2.6–3.5 Å from the chlorine
atom, thus providing van der Waals’ interactions or H-bonds to generate the additional bind-
ing affinity observed for 3Cl,4-HPA (Fig 4B). The presence of a single hydroxyl group at posi-
tion 2, as in 2-HPA, rather than at position 4, would eliminate the possibility of favorable
interactions with AspB36, resulting in the lack of NadR regulation by 2-HPA described previ-
ously [20]. Finally, salicylate is presumably unable to specifically bind NadR due to the
2-hydroxyl substitution and the shorter aliphatic chain connecting its carboxylate group (Fig
1A): the compound simply seems too small to simultaneously establish the network of benefi-
cial bonds observed in the NadR/HPA interactions.
Fig 4. Atomic details of NadR/HPA interactions. A) A stereo-view zoom into the binding pocket showing side chain sticks for all interactions between
NadR and 4-HPA. Green and blue ribbons depict NadR chains A and B, respectively. 4-HPA is shown in yellow sticks, with oxygen atoms in red. A water
molecule is shown by the red sphere. H-bonds up to 3.6Å are shown as dashed lines. The entire set of residues making H-bonds or non-bonded contacts
with 4-HPA is as follows: SerA9, AsnA11, LeuB21, MetB22, PheB25, LeuB29, AspB36, TrpB39, ArgB43, ValB111 and TyrB115 (automated analysis
performed using PDBsum [44] and verified manually). Residues AsnA11 and ArgB18 likely make indirect yet local contributions to ligand binding, mainly by
stabilizing the position of AspB36. Bond distances for interacting polar atoms are provided in Table 3. Side chains mediating hydrophobic interactions are
shown in orange. (B) Amodel was prepared to visualize putative interactions of 3Cl,4-HPA (pink) with NadR, revealing the potential for additional contacts
(dashed lines) of the chloro moiety (green stick) with LeuB29 and AspB36.
doi:10.1371/journal.ppat.1005557.g004
Table 3. List of 4-HPA atoms bound to NadR via ionic interactions and/or H-bonds.
4-HPA atom NadR residue/atom Distance (Å)
O2 TrpB39/NE1 2.83
O2 ArgB43/NH1 2.76
O1 ArgB43/NH1 3.84
O1 SerA9/OG 2.75
O1 TyrB115/OH 2.50
O2 Water (*Ser9/Asn11) 2.88
OH AspB36/OD1/OD2 3.6/3.7
* Bond distance between the ligand carboxylate group and the water molecule, which in turn makes H-
bond to the SerA9 and AsnA11 side chains.
doi:10.1371/journal.ppat.1005557.t003
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Analysis of the pockets reveals the molecular basis for asymmetric
binding and stoichiometry
We attempted to investigate further the binding stoichiometry using solution-based tech-
niques. However, studies based on tryptophan fluorescence were confounded by the fluores-
cence of the HPA ligands, and isothermal titration calorimetry (ITC) was unfeasible due to the
need for very high concentrations of NadR in the ITC chamber (due to the relatively low affin-
ity), which exceeded the solubility limits of the protein. However, it was possible to calculate
the binding stoichiometry of the NadR-HPA interactions using an SPR-based approach. In
SPR, the signal measured is proportional to the total molecular mass proximal to the sensor
surface; consequently, if the molecular weights of the interactors are known, then the stoichi-
ometry of the resulting complex can be determined [24]. This approach relies on the assump-
tion that the captured protein (‘the ligand’, according to SPR conventions) is 100% active and
freely-accessible to potential interactors (‘the analytes’). This assumption is likely valid for this
pair of interactors, for two main reasons. Firstly, NadR is expected to be covalently immobi-
lized on the sensor chip as a dimer in random orientations, since it is a stable dimer in solution
and has sixteen lysines well-distributed around its surface, all able to act as potential sites for
amine coupling to the chip, and none of which are close to the ligand-binding pocket. Sec-
ondly, the HPA analytes are all very small (MW 150–170, Fig 1A) and therefore are expected
to be able to diffuse readily into all potential binding sites, irrespective of the random orienta-
tions of the immobilized NadR dimers on the chip.The stoichiometry of the NadR-HPA inter-
actions was determined using Eq 1 (see Materials and Methods), and revealed stoichiometries
of 1.13 for 4-HPA, 1.02 for 3-HPA, and 1.21 for 3Cl,4-HPA, strongly suggesting that one NadR
dimer bound to 1 HPA analyte molecule.
The crystallographic data, supported by the SPR studies of binding stoichiometry, revealed
the lack of a second 4-HPA molecule in the homodimer, suggesting negative co-operativity, a
phenomenon previously described for the MTH313/salicylate interaction [17] and for other
MarR family proteins [16]. To explore the molecular basis of asymmetry in holo-NadR, we
superposed its ligand-free monomer (chain A) onto the ligand-occupied monomer (chain B).
Overall, the superposition revealed a high degree of structural similarity (Cα root mean square
deviation (rmsd) of 1.5Å), though on closer inspection a rotational difference of ~9 degrees
along the long axis of helix α6 was observed, suggesting that 4-HPA induced a slight conforma-
tional change (Fig 5A). However, since residues of helix α6 were not directly involved in ligand
binding, an explanation for the lack of 4-HPA in monomer A did not emerge by analyzing
only these backbone atom positions, suggesting that a more complex series of allosteric events
may occur. Indeed, we noted interesting differences in the side chains of Met22, Phe25 and
Arg43, which in monomer B are used to contact the ligand while in monomer A they partially
occupied the pocket and collectively reduced its volume significantly. Specifically, upon analy-
sis with the CASTp software [25], the pocket in chain B containing the 4-HPA exhibited a total
volume of approximately 370 Å3, while the pocket in chain A was occupied by these three side
chains that adopted ‘inward’ positions and thereby divided the space into a few much smaller
pockets, each with volume< 50 Å3, evidently rendering chain A unfavorable for ligand bind-
ing. Most notably, atomic clashes between the ligand and the side chains of MetA22, PheA25
and ArgA43 would occur if 4-HPA were present in the monomer A pocket (Fig 5B). Subse-
quently, analyses of the pockets in apo-NadR revealed that in the absence of ligand the long
Arg43 side chain was always in the open ‘outward’ position compatible with binding to the
4-HPA carboxylate group. In contrast, the apo-formMet22 and Phe25 residues were still
encroaching the spaces of the 4-hydroxyl group and the phenyl ring of the ligand, respectively
(Fig 5C). The ‘outward’ position of Arg43 generated an open apo-form pocket with volume
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approximately 380Å3. Taken together, these observations suggest that Arg43 is a major deter-
minant of ligand binding, and that its ‘inward’ position inhibits the binding of 4-HPA to the
empty pocket of holo-NadR.
Finally, we applied 15N heteronuclear solution NMR spectroscopy to examine the interac-
tion of 4-HPA with apo NadR. We collected NMR spectra on NadR in the presence and
absence of 4-HPA (see Materials and Methods). The 1H-15N TROSY-HSQC spectrum of apo-
NadR, acquired at 25°C, displayed approximately 140 distinct peaks (Fig 6A), most of which
correspond to backbone amide N-H groups. The broad spectral dispersion and the number of
peaks observed, which is close to the number of expected backbone amide N-H groups for this
polypeptide, confirmed that apo-NadR is well-folded under these conditions and exhibits one
conformation appreciable on the NMR timescale, i.e. in the NMR experiments at 25°C, two or
more distinct conformations of apo-NadR monomers were not readily apparent. Upon the
addition of 4-HPA, over 45 peaks showed chemical shift perturbations, i.e. changed position in
the spectrum or disappeared, while the remaining peaks remained unchanged. This observa-
tion showed that 4-HPA was able to bind NadR and induce notable changes in specific regions
of the protein.
However, in the presence of 4-HPA, the 1H-15N TROSY-HSQC spectrum of NadR dis-
played approximately 140 peaks, as for apo-NadR, i.e. two distinct stable conformations (that
might have potentially revealed the molecular asymmetry observed crystallographically) were
not notable. Considering the small size, fast diffusion and relatively low binding affinity of
4-HPA, it would not be surprising if the ligand associates and dissociates rapidly on the NMR
time scale, resulting in only one set of peaks whose chemical shifts represent the average envi-
ronment of the bound and unbound states. Interestingly, by cooling the samples to 10°C, we
observed that a number of those peaks strongly affected by 4-HPA (and therefore likely to be
in the ligand-binding site) demonstrated evidence of peak splitting, i.e. a tendency to become
two distinct peaks rather than one single peak (Fig 6B and 6C). These doubled peaks may
therefore reveal that the cooler temperature partially trapped the existence in solution of two
distinct states, in presence or absence of 4-HPA, with minor conformational differences occur-
ring at least in proximity to the binding pocket. Although more comprehensive NMR
Fig 5. Structural differences of NadR in ligand-bound or free forms. (A) Aligned monomers of holo-NadR (chain A: green; chain B: blue), reveal major
overall differences by the shift of helix α6. (B) Comparison of the two binding pockets in holo-NadR shows that in the ligand-free monomer A (green) residues
Met22, Phe25 and Arg43 adopt ‘inward’ positions (highlighted by arrows) compared to the ligand-occupied pocket (blue residues); these ‘inward’
conformations appear unfavorable for binding of 4-HPA due to clashes with the 4-hydroxyl group, the phenyl ring and the carboxylate group, respectively. In
these crystals, the ArgA43 side chain showed two alternate conformations, modelled with 50% occupancy in each state, as indicated by the two ‘mirrored’
arrows. The inner conformer is the one that would display major clashes if 4-HPA were present. (C) Comparison of the empty pocket from holo-NadR (green
residues) with the four empty pockets of apo-NadR (grey residues), shows that in the absence of 4-HPA the Arg43 side chain is always observed in the
‘outward’ conformation.
doi:10.1371/journal.ppat.1005557.g005
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experiments and full chemical shift assignment of the spectra would be required to precisely
define this multi-state behavior, the NMR data clearly demonstrate that NadR exhibits confor-
mational flexibility which is modulated by 4-HPA in solution.
Apo-NadR structures reveal intrinsic conformational flexibility
The apo-NadR crystal structure contained two homodimers in the asymmetric unit (chains A
+B and chains C+D). Upon overall structural superposition, these dimers revealed a few minor
differences in the α6 helix (a major component of the dimer interface) and the helices α4-α5
(the DNA binding region), and an rmsd of 1.55Å (Fig 7A). Similarly, the entire holo-homodi-
mer could be closely superposed onto each of the apo-homodimers, showing rmsd values of
1.29Å and 1.31Å, and with more notable differences in the α6 helix positions (Fig 7B). The
slightly larger rmsd between the two apo-homodimers, rather than between apo- and holo-
homodimers, further indicate that apo-NadR possesses a notable degree of intrinsic conforma-
tional flexibility.
4-HPA stabilizes concerted conformational changes in NadR that
prevent DNA-binding
To further investigate the conformational rearrangements of NadR, we performed local struc-
tural alignments using only a subset of residues in the DNA-binding helix (α4). By selecting
and aligning residues Arg64-Ala77 of one α4 helix per dimer, superposition of the holo-homo-
dimer onto the two apo-homodimers revealed differences in the monomer conformations of
each structure. While one monomer from each structure was closely superimposable (Fig 8A,
Fig 6. NMR spectra of NadR in the presence and absence of 4-HPA. (A) Superposition of two 1H-15N TROSY-HSQC spectra recorded at 25°C on apo-
NadR (cyan) and on NadR in the presence of 4-HPA (red). (B,C)Overlay of selected regions of the 1H-15N TROSY-HSQC spectra acquired at 25°C of apo-
NadR (cyan) and NadR/4-HPA (red) superimposed with the spectra acquired at 10°C of apo-NadR (blue) and NadR/4-HPA (green). The spectra acquired at
10°C are excluded from panel A for simplicity.
doi:10.1371/journal.ppat.1005557.g006
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left side), the second monomer displayed quite large differences (Fig 8A, right side). Most nota-
bly, the position of the DNA-binding helix α4 shifted by as much as 6 Å (Fig 8B). Accordingly,
helix α4 was also found to be one of the most dynamic regions in previous HDX-MS analyses
of apo-NadR in solution [21].
However, structural comparisons revealed that the shift of holo-NadR helix α4 induced by
the presence of 4-HPA was also accompanied by several changes at the holo dimer interface,
while such extensive structural differences were not observed in the apo dimer interfaces, par-
ticularly notable when comparing the α6 helices (S3 Fig). In summary, compared to ligand-sta-
bilized holo-NadR, apo-NadR displayed an intrinsic flexibility focused in the DNA-binding
region. This was also evident in the greater disorder (i.e. less well-defined electron density) in
the β1-β2 loops of the apo dimers (density for 16 residues per dimer was missing) compared to
the holo dimer (density for only 3 residues was missing).
In holo-NadR, the distance separating the two DNA-binding α4 helices was 32 Å, while in
apo-NadR it was 29 Å for homodimer AB, and 34 Å for homodimer CD (Fig 8C). Thus, the
apo-homodimer AB presented the DNA-binding helices in a conformation similar to that
observed in the protein:DNA complex of OhrR:ohrA from Bacillus subtilis [26] (Fig 8C). Inter-
estingly, OhrR contacts ohrA across 22 base pairs (bp), and similarly the main NadR target
sites identified in the nadA promoter (the operators Op I and Op II) both span 22 bp [9, 10].
Pairwise superpositions showed that the NadR apo-homodimer AB was the most similar to
OhrR (rmsd 2.6 Å), while the holo-homodimer was the most divergent (rmsd 3.3 Å) (Fig 8C).
Assuming the same DNA-binding mechanism is used by OhrR and NadR, the apo-homodimer
AB seems ideally pre-configured for DNA binding, while 4-HPA appeared to stabilize holo-
NadR in a conformation poorly suited for DNA binding. Specifically, in addition to the differ-
ent inter-helical translational distances, the α4 helices in the holo-NadR homodimer were also
reoriented, resulting in movement of α4 out of the major groove, by up to 8Å, and presumably
preventing efficient DNA binding in the presence of 4-HPA (Fig 8D). When aligned with
OhrR, the apo-homodimer CD presented yet another different intermediate conformation
(rmsd 2.9Å), apparently not ideally pre-configured for DNA binding, but which in solution
can presumably readily adopt the AB conformation due to the intrinsic flexibility described
above.
Fig 7. Overall apo- and holo-NadR structures are similar. (A) Pairwise alignment of the two distinct apo-NadR homodimers (AB and CD) present in the
apo-NadR crystals. (B) Alignment of the holo-NadR homodimer (green and blue chains) onto the apo-NadR homodimers. Here, larger differences are
observed in the α6 helices (top).
doi:10.1371/journal.ppat.1005557.g007
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NadR residues His7, Ser9, Asn11 and Phe25 are essential for regulation
of NadA expression in vivo
While previous studies had correctly suggested the involvement of several NadR residues in
ligand binding [21], the crystal structures presented here revealed additional residues with pre-
viously unknown roles in dimerization and/or binding to 4-HPA. To explore the functional
involvement of these residues, we characterized the behavior of four new NadR mutants (H7A,
S9A, N11A and F25A) in an in vivo assay using the previously described MC58-Δ1843 nadR-
null mutant strain [9], which was complemented either by wild-type nadR or by the nadR
mutants. NadA protein abundance levels were assessed by Western blotting to evaluate the
ability of the NadR mutants to repress the nadA promoter, in the presence or absence of
4-HPA. The nadRH7A, S9A and F25A complemented strains showed hyper-repression of
nadA expression in vivo, i.e. these mutants repressed nadAmore efficiently than the NadRWT
Fig 8. Structural comparisons of NadR andmodelling of interactions with DNA. (A) The holo-homodimer structure is shown as green and blue
cartoons, for chain A and B, respectively, while the two homodimers of apo-NadR are both cyan and pale blue for chains A/C and B/D, respectively. The three
homodimers (chains AB holo, AB apo, and CD apo) were overlaid by structural alignment exclusively of all heavy atoms in residues R64-A77 (shown in red,
with side chain sticks) of chains A holo, A apo, and C apo, belonging to helix α4 (left). The α4 helices aligned closely, Cα rmsd 0.2Å for 14 residues. (B) The
relative positions of the α4 helices of the 4-HPA-bound holo homodimer chain B (blue), and of apo homodimers AB and CD (showing chains B and D) in pale
blue. Dashes indicate the Ala77 Cα atoms, in the most highly shifted region of the ‘non-fixed’ α4 helix. (C) The double-stranded DNAmolecule (grey cartoon)
from the OhrR-ohrA complex is shown after superposition with NadR, to highlight the expected positions of the NadR α4 helices in the DNAmajor grooves.
The proteins share ~30% amino acid sequence identity. For clarity, only the α4 helices are shown in panels (B) and (C). (D) Upon comparison with the
experimentally-determined OhrR:ohrA structure (grey), the α4 helix of holo-NadR (blue) is shifted ~8Å out of the major groove.
doi:10.1371/journal.ppat.1005557.g008
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protein, either in the presence or absence of 4-HPA, while complementation with wild-type
nadR resulted in high production of NadA only in the presence of 4-HPA (Fig 9). Interestingly,
and on the contrary, the nadR N11A complemented strain showed hypo-repression (i.e. exhib-
ited high expression of nadA both in absence and presence of 4-HPA). This mutagenesis data
revealed that NadR residues His7, Ser9, Asn11 and Phe25 play key roles in the ligand-mediated
regulation of NadR; they are each involved in the controlled de-repression of the nadA pro-
moter and synthesis of NadA in response to 4-HPA in vivo.
Discussion
NadA is a surface-exposed meningococcal protein contributing to pathogenesis, and is one of
three main antigens present in the vaccine Bexsero [6]. A detailed understanding of the in vitro
repression of nadA expression by the transcriptional regulator NadR is important, both
because it is a relevant disease-related model of how small-molecule ligands can regulate MarR
family proteins and thereby impact bacterial virulence, and because nadA expression levels are
linked to the prediction of vaccine coverage [20] [27]. The repressive activity of NadR can be
relieved by hydroxyphenylacetate (HPA) ligands [20], and HDX-MS studies previously indi-
cated that 4-HPA stabilizes dimeric NadR in a configuration incompatible with DNA binding
[21]. Despite these and other studies [16], the molecular mechanisms by which ligands regulate
MarR family proteins are relatively poorly understood and likely differ depending on the spe-
cific ligand. Given the importance of NadR-mediated regulation of NadA levels in the contexts
of meningococcal pathogenesis, we sought to characterize NadR, and its interaction with
ligands, at atomic resolution.
Firstly, we confirmed that NadR is dimeric in solution and demonstrated that it retains its
dimeric state in the presence of 4-HPA, indicating that induction of a monomeric status is not
the manner by which 4-HPA regulates NadR. These observations were in agreement with (i) a
previous study of NadR performed using SEC and mass spectrometry [21], and (ii) crystallo-
graphic studies showing that several MarR homologues are dimeric [16]. We also used struc-
ture-guided site-directed mutagenesis to identify an important conserved residue, Leu130,
which stabilizes the NadR dimer interface, knowledge of which may also inform future studies
to explore the regulatory mechanisms of other MarR family proteins. Secondly, we assessed the
thermal stability and unfolding of NadR in the presence or absence of ligands. All DSC profiles
showed a single peak, suggesting that a single unfolding event simultaneously disrupted the
dimer and the monomer. HPA ligands specifically increased the stability of NadR. The largest
Fig 9. Structure-based point mutations shed light on ligand-induced regulation of NadR.Western blot
analyses of wild-type (WT) strain (lanes 1–2) or isogenic nadR knockout strains (ΔNadR) complemented to
express the indicated NadRWT or mutant proteins (lanes 3–12) or not complemented (lanes 13–14), grown
in the presence (even lanes) or absence (odd lanes) of 5mM 4-HPA, showing NadA and NadR expression.
Complementation of ΔNadR with WT NadR enables induction of nadA expression by 4-HPA. The H7A, S9A
and F25Amutants efficiently repress nadA expression but are less ligand-responsive than WT NadR. The
N11Amutant does not efficiently repress nadA expression either in presence or absence of 4-HPA. (The
protein abundance levels of the meningococcal factor H binding protein (fHbp) were used as a gel loading
control).
doi:10.1371/journal.ppat.1005557.g009
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effects were induced by the naturally-occurring compounds 4-HPA and 3Cl,4-HPA, which, in
SPR assays, were found to bind NadR with KD values of 1.5 mM and 1.1 mM, respectively.
Although these NadR/HPA interactions appeared rather weak, their distinct affinities and
specificities matched their in vitro effects [9, 20] and their biological relevance appears similar
to previous proposals that certain small molecules, including some antibiotics, in the millimo-
lar concentration range may be broad inhibitors of MarR family proteins [13, 17]. Indeed,
4-HPA is found in human saliva [19] and 3Cl,4-HPA is produced during inflammatory pro-
cesses [28], suggesting that these natural ligands are encountered by N.meningitidis in the
mucosa of the oropharynx during infections. It is also possible that NadR responds to currently
unidentified HPA analogues. Indeed, in the NadR/4-HPA complex there was a water molecule
close to the carboxylate group and also a small unfilled tunnel ~5Å long, both factors suggest-
ing that alternative larger ligands could occupy the pocket. It is conceivable that such putative
ligands may establish different bonding networks, potentially binding in a 2:2 ratio, rather than
the 1:2 ratio observed herein. The ability to respond to various ligands might enable NadR in
vivo to orchestrate multiple response mechanisms and modulate expression of genes other
than nadA. Ultimately, confirmation of the relevance of each ligand will require a deeper
understanding of the available concentration in vivo in the host niche during bacterial coloni-
zation and inflammation.
Here, we determined the first crystal structures of apo-NadR and holo-NadR. These experi-
mentally-determined structures enabled a new detailed characterization of the ligand-binding
pocket. In holo-NadR, 4-HPA interacted directly with at least 11 polar and hydrophobic resi-
dues. Several, but not all, of these interactions were predicted previously by homology model-
ling combined with ligand docking in silico [21]. Subsequently, we established the functional
importance of His7, Ser9, Asn11 and Phe25 in the in vitro response of meningococcus to
4-HPA, via site-directed mutagenesis. More unexpectedly, the crystal structure revealed that
only one molecule of 4-HPA was bound per NadR dimer. We confirmed this stoichiometry in
solution using SPR methods. We also used heteronuclear NMR spectroscopy to detect substan-
tial conformational changes of NadR occurring in solution upon addition of 4-HPA. Moreover,
NMR spectra at 10°C suggested the existence of two distinct conformations of NadR in the
vicinity of the ligand-binding pocket. More powerfully, our unique crystallographic observa-
tion of this ‘occupied vs unoccupied site’ asymmetry in the NadR/4-HPA interaction is, to our
knowledge, the first example reported for a MarR family protein. Structural analyses suggested
that ‘inward’ side chain positions of Met22, Phe25 and especially Arg43 precluded binding of a
second ligand molecule. Such a mechanism indicates negative cooperativity, which may
enhance the ligand-responsiveness of NadR.
Comparisons of the NadR/4-HPA complex with available MarR family/salicylate complexes
revealed that 4-HPA has a previously unobserved binding mode. Briefly, in theM. thermoauto-
trophicumMTH313 dimer, one molecule of salicylate binds in the pocket of each monomer,
though with two rather different positions and orientations, only one of which (site-1) is
thought to be biologically relevant [17] (Fig 10A). In the S. tokodaii protein ST1710, salicylate
binds to the same position in each monomer of the dimer, in a site equivalent to the putative
biologically relevant site of MTH313 [18] (Fig 10B). Unlike other MarR family proteins which
revealed multiple ligand binding interactions, we observed only 1 molecule of 4-HPA bound to
NadR, suggesting a more specific and less promiscuous interaction. In NadR, the single mole-
cule of 4-HPA binds in a position distinctly different from the salicylate binding site: translated
by> 10 Å and with a 180° inverted orientation (Fig 10C).
Interestingly, a crystal structure was previously reported for a functionally-uncharacterized
meningococcal homologue of NadR, termed NMB1585, which shares 16% sequence identity
with NadR [29]. The two structures can be closely aligned (rmsd 2.3 Å), but NMB1585 appears
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unsuited for binding HPAs, since its corresponding ‘pocket’ region is occupied by several bulky
hydrophobic side chains. It can be speculated that MarR family members have evolved sepa-
rately to engage distinct signaling molecules, thus enabling bacteria to use the overall conserved
MarR scaffold to adapt and respond to diverse changing environmental stimuli experienced in
their natural niches. Alternatively, it is possible that other MarR homologues (e.g. NMB1585)
may have no extant functional binding pocket and thus may have lost the ability to respond to
a ligand, acting instead as constitutive DNA-binding regulatory proteins.
The apo-NadR crystal structures revealed two dimers with slightly different conformations,
most divergent in the DNA-binding domain. It is not unusual for a crystal structure to reveal
multiple copies of the same protein in very slightly different conformations, which are likely
representative of the lowest-energy conformations sampled by the dynamic ensemble of molec-
ular states occurring in solution, and which likely have only small energetic differences, as
described previously for MexR (a MarR protein) [30] or more recently for the solute-binding
protein FhuD2 [31, 32]. Further, the holo-NadR structure was overall more different from the
two apo-NadR structures (rmsd values ~1.3Å), suggesting that the ligand selected and stabi-
lized yet another conformation of NadR. These observations suggest that 4-HPA, and poten-
tially other similar ligands, can shift the molecular equilibrium, changing the energy barriers
that separate active and inactive states, and stabilizing the specific conformation of NadR
poorly suited to bind DNA.
Comparisons of the apo- and holo-NadR structures revealed that the largest differences
occurred in the DNA-binding helix α4. The shift of helix α4 in holo-NadR was also accompa-
nied by rearrangements at the dimer interface, involving helices α1, α5, and α6, and this holo-
form appeared poorly suited for DNA-binding when compared with the known OhrR:ohrA
complex [26]. While some flexibility of helix α4 was also observed in the two apo-structures,
concomitant changes in the dimer interfaces were not observed, possibly due to the absence of
ligand. One of the two conformations of apo-NadR appeared ideally suited for DNA-binding.
Overall, these analyses suggest that the apo-NadR dimer has a pre-existing equilibrium that
samples a variety of conformations, some of which are compatible with DNA binding. This
intrinsically dynamic nature underlies the possibility for different conformations to inter-
Fig 10. NadR shows a ligand binding site distinct from other MarR homologues. (A) A structural alignment of MTH313 chains A and B shows that
salicylate is bound in distinct locations in each monomer; site-1 (thought to be the biologically relevant site) and site-2 differ by ~7Å (indicated by black dotted
line) and also by ligand orientation. (B) A structural alignment of MTH313 chain A and ST1710 (pink) (Cα rmsd 2.3Å), shows that they bind salicylate in
equivalent sites (differing by only ~3Å) and with the same orientation. (C) Addition of holo-NadR (chain B, blue) to the alignment reveals that bound 4-HPA
differs in position by > 10 Å compared to salicylate, and adopts a novel orientation.
doi:10.1371/journal.ppat.1005557.g010
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convert or to be preferentially selected by a regulatory ligand, as generally described in the ‘con-
formational selection’ model for protein-ligand interactions (the Monod-Wyman-Changeux
model), rather than an ‘induced fit’ model (Koshland-Nemethy-Filmer) [33]. The noted flexi-
bility may also explain how NadR can adapt to bind various DNA target sequences [10] with
slightly different structural features. Subsequently, upon ligand binding, holo-NadR adopts a
structure less suited for DNA-binding and this conformation is selected and stabilized by a net-
work of protein-ligand interactions and concomitant rearrangements at the NadR holo dimer
interface. In an alternative and less extensive manner, the binding of two salicylate molecules
to theM. thermoautotrophicum protein MTH313 appeared to induce large changes in the
wHTH domain, which was associated with reduced DNA-binding activity [17].
Here we have presented two new crystal structures of the transcription factor, NadR, which
regulates expression of the meningococcal surface protein, virulence factor and vaccine antigen
NadA. Detailed structural analyses provided a molecular explanation for the ligand-responsive
regulation by NadR on the majority of the promoters of meningococcal genes regulated by
NadR, including nadA [10]. Intriguingly, NadR exhibits a reversed regulatory mechanism on a
second class of promoters, includingmafA of the multiple adhesin family–i.e. NadR represses
these genes in the presence but not absence of 4-HPA. The latter may influence the surface
abundance or secretion ofmaf proteins, an emerging class of highly conserved meningococcal
putative adhesins and toxins with many important roles [11, 12]. Further work is required to
investigate how the two different promoter types influence the ligand-responsiveness of NadR
during bacterial infection and may provide insights into the regulatory mechanisms occurring
during these host-pathogen interactions. Ultimately, knowledge of the ligand-dependent activ-
ity of NadR will continue to deepen our understanding of nadA expression levels, which influ-
ence meningococcal pathogenesis.
Materials and Methods
Bacterial strains, culture conditions and mutant generation
In this study we usedN.meningitidisMC58 wild type strain and related mutant derivatives. The
MC58 isolate was kindly provided to us by Professor E. Richard Moxon, University of Oxford,
UK, and was previously submitted to the Meningococcal Reference Laboratory, Manchester, UK
[34]. Strains were routinely cultured, stocked, and transformed as described previously [10]. To
generate N.meningitidisMC58mutant strains expressing only the amino acid substituted forms
of NadR, plasmids containing the sequence of nadRmutated to insert alanine codons to replace
His7, Ser9, Asn11 or Phe25 were constructed using the QuikChange II XL Site-Directed Muta-
genesis Kit (Stratagene). The nadR gene (also termed NMB1843) was mutated in the pComEry-
1843 plasmid using couples of mutagenic primers (forward and reverse). The resulting plasmids
were named pComEry-1843H7A, -1843S9A, -1843N11A or -1843F25A, and contained a site-
directed mutant allele of the nadR gene, in which the selected codons were respectively substi-
tuted by a GCG alanine codon, and were used for transformation of the MC-Δ1843 strain. Total
lysates from single colonies of all transformants were used as a template for PCR analysis to con-
firm the correct insertion by double homologous recombinant event. When indicated, bacterial
strains were grown in presence of 5 mM 4-HPA (MW 152, Sigma-Aldrich).
Molecular cloning
The preparation of the expression construct enabling production of soluble NadR with an N-
terminal His-tag followed by a thrombin cleavage site (MGSSHHHHHHSSGLVPR#GSH-)
(where the arrow indicates the cleavage site) and then NadR residues M1-S146 (Uniprot code
Q7DD70), and methods to generate site-directed mutants, were described previously [21].
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Briefly, site-directed mutagenesis was performed using two overlapping primers containing the
desired mutation to amplify pET15b containing several NadR variants. (Full oligonucleotide
sequences of primers are available upon request). 1–10 ng of plasmid DNA template were
amplified using Kapa HiFi DNA polymerase (Kapa Biosystems) and with the following cycling
conditions: 98°C for 5 min, 15 cycles of (98°C for 30 s, 60°C for 30 s, 72°C for 6 min) followed
by a final extension of 10 min at 72°C. Residual template DNA was digested by 30 min incuba-
tion with FastDigest DpnI (Thermo Scientific) at 37°C and 1 μl of this reaction was used to
transform E. coli DH5α competent cells. The full recombinant tagged NadR protein generated
contained 166 residues, with a theoretical MW of 18746, while after thrombin-cleavage the
untagged protein contained 149 residues, with a theoretical MW of 16864.
Protein production and purification
The NadR expression constructs (wild-type or mutant clones) were transformed into E. coli BL21
(DE3) cells and were grown at 37°C in Luria-Bertani (LB) medium supplemented with 100 μg/mL
ampicillin, until an OD600 of 0.5 was reached. Target protein production was induced by the addi-
tion of 1 mM IPTG followed by incubation with shaking overnight at 21°C. For production of the
selenomethionine (SeMet) derivative form of NadR for crystallization studies, essentially the same
procedure was followed, but using the E. coli B834 strain grown in a modified M9minimal
medium supplemented with 40 mg/L L-SeMet. For production of 15N-labeled NadR for NMR
analyses, the EnPresso B Defined Nitrogen-free medium (Sigma-Aldrich) was used; in brief, BL21
(DE3) cells were grown in BioSilta medium at 30°C for 30 h, and production of the 15N-labeled
NadR was enabled by the addition of 2.5 g/L 15NH4Cl and further incubation for 2 days.
Cells were harvested by centrifugation (6400 g, 30 min, 4°C), resuspended in 20 mMHEPES
pH 8.0, 300 mMNaCl, 20 mM imidazole, and were lysed by sonication (Qsonica Q700). Cell
lysates were clarified by centrifugation at 2800 g for 30 min, and the supernatant was filtered
using a 0.22 μmmembrane (Corning filter system) prior to protein purification. NadR was puri-
fied by affinity chromatography using an AKTA purifier (GE Healthcare). All steps were per-
formed at room temperature (18–26°C), unless stated otherwise. The filtered supernatant was
loaded onto an Ni-NTA resin (5 mL column, GE Healthcare), and NadR was eluted using 4 steps
of imidazole at 20, 30, 50 and 250 mM concentration, at a flow rate of 5 mL/min. Eluted fractions
were examined by reducing and denaturing SDS-PAGE analysis. Fractions containing NadR
were identified by a band migrating at ~17 kDa, and were pooled. The N-terminal 6-His tag was
removed enzymatically using the Thrombin CleanCleave Kit (Sigma-Aldrich). Subsequently, the
sample was reloaded on the Ni-NTA resin to capture the free His tag (or unprocessed tagged pro-
tein), thus allowing elution in the column flow-through of tagless NadR protein, which was used
in all subsequent studies. The NadR sample was concentrated and loaded onto a HiLoad Super-
dex 75 (16/60) preparative size-exclusion chromatography (SEC) column equilibrated in buffer
containing 20 mMHEPES pH 8.0, 150 mMNaCl, at a flow-rate of 1 mL/min. NadR protein was
collected and the final yield of purified protein obtained from 0.5 L LB growth medium was
approximately 8 mg (~2 mg protein per g wet biomass). Samples were used immediately for crys-
tallization or analytical experiments, or were frozen for storage at -20°C.
SE-HPLC/MALLS analyses
MALLS analyses were performed online with SE-HPLC using a Dawn TREOS MALLS detector
(Wyatt Corp., Santa Barbara, CA, USA) and an incident laser wavelength of 658 nm. The
intensity of the scattered light was measured at 3 angles simultaneously. Data analysis was per-
formed using the Astra V software (Wyatt) to determine the weighted-average absolute molec-
ular mass (MW), the polydispersity index (MW/Mn) and homogeneity (Mz/Mn) for each
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oligomer present in solution. Normalization of the MALLS detectors was performed in each
analytical session by use of bovine serum albumin.
Differential scanning calorimetry
The thermal stability of NadR proteins was assessed by differential scanning calorimetry (DSC)
using a MicroCal VP-Capillary DSC instrument (GE Healthcare). NadR samples were pre-
pared at a protein concentration of 0.5 mg/mL (~30 μM) in buffer containing 20 mMHEPES,
300 mMNaCl, pH 7.4, with or without 6 mMHPA or salicylate. The DSC temperature scan
ranged from 10°C to 110°C, with a thermal ramping rate of 200°C per hour and a 4 second fil-
ter period. Data were analyzed by subtraction of the reference data for a sample containing
buffer only, using the Origin 7 software. All experiments were performed in triplicate, and
mean values of the melting temperature (Tm) were determined.
Surface plasmon resonance (SPR)
Determination of equilibrium dissociation constant, KD. Surface plasmon resonance
binding analyses were performed using a Biacore T200 instrument (GE Healthcare) equilibrated
at 25°C. The ligand (NadR) was covalently immobilized by amine-coupling on a CM-5 sensor
chip (GE Healthcare), using 20 μg/mL purified protein in 10 mM sodium acetate buffer pH 5,
injected at 10 μl/min for 120 s until ~9000 response units (RU) were captured. A high level of
ligand immobilization was required due to the small size of the analytes. An unmodified surface
was used as the reference channel. Titrations with analytes (HPAs or salicylate) were performed
with a flow-rate of 30 μl/min, injecting the compounds in a concentration range of 10 μM to 20
mM, using filtered running buffer containing Phosphate Buffered Saline (PBS) with 0.05%
Tween-20, pH 7.4. Following each injection, sensor chip surfaces were regenerated with a 30-sec-
ond injection of 10 mMGlycine pH 2.5. Each titration series contained 20 analyte injections and
was performed in triplicate. Titration experiments with long injection phases (> 15 mins) were
used to enable steady-state analyses. Data were analyzed using the BIAcore T200 evaluation soft-
ware and the steady-state affinity model. A buffer injection was subtracted from each curve, and
reference sensorgrams were subtracted from experimental sensorgrams to yield curves represent-
ing specific binding. The equilibrium dissociation constant, KD, was determined from the plot of
RUeq against analyte concentration (S2 Fig), as described previously [35]. Determination of bind-
ing stoichiometry: From each plot of RUeq against analyte concentration, obtained from triplicate
experiments, the Rmax value (maximum analyte binding capacity of the surface) was extrapolated
from the experimental data (S2 Fig). Stoichiometry was calculated using the molecular weight of
dimeric NadR as ligand molecule (MWligand) and the molecular weights of the HPA analyte mol-
ecules (MWanalyte), and the following equation:
Stoichiometry ¼ Rmax MWligand
MWanalyte  Rligand
ð1Þ
where Rligand is recorded directly from the sensorgram during ligand immobilization prior to the
titration series, as described previously [24]. The stoichiometry derived therefore represented the
number of HPAmolecules bound to one dimeric NadR protein.
Crystallization of NadR in the presence or absence of 4-HPA
Purified NadR was concentrated to 2.7 mg/mL (~160 μM) using a centrifugal concentration
device (Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-10 membrane with cut-off size
10 kDa; Millipore) running at 600 g in a bench top centrifuge (Thermo Scientific IEC CL40R)
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refrigerated at 2–8°C. To prepare holo-NadR samples, HPA ligands were added at a 200-fold molar
excess prior to the centrifugal concentration step. The concentrated holo- or apo-NadR was sub-
jected to crystallization trials performed in 96-well low-profile Intelli-Plates (Art Robbins) or
96-well low-profile Greiner crystallization plates, using a nanodroplet sitting-drop vapour-diffusion
format and mixing equal volumes (200 nL) of protein samples and crystallization buffers using a
Gryphon robot (Art Robbins). Crystallization trays were incubated at 20°C. Crystals of apo-NadR
were obtained in 50% PEG 3350 and 0.13 M di-Ammonium hydrogen citrate, whereas crystals of
SeMet–NadR in complex with 4-HPA grew in condition H4 of theMorpheus screen (Molecular
Dimensions), which contains 37.5% of the pre-mixed precipitant stock MPD_P1K_PEG 3350,
buffer system 1 and 0.1 M amino acids, at pH 6.5. All crystals were mounted in cryo-loops using
10% ethylene glycol or 10% glycerol as cryo-protectant before cooling to 100 K for data collection.
X-ray diffraction data collection and structure determination
X-ray diffraction data from crystals of apo-NadR and SeMet–NadR/4-HPA were collected on
beamline PXII-X10SA of the Swiss Light Source (SLS) at the Paul Scherrer Institut (PSI), Villigen,
Switzerland. All diffraction data were processed with XDS [36] and programs from the CCP4
suite [37]. Crystals of apo-NadR and 4-HPA-bound SeMet-NadR belonged to space group P43
21 2 (see Table 2). Apo-NadR crystals contained four molecules (two dimers) in the asymmetric
unit (Matthews coefficient 2.25 Å3 Da−1, for a solvent content of 45%), while crystals of SeMet–
NadR/4-HPA contained two molecules (one dimer) in the asymmetric unit (Matthews coeffi-
cient 1.98 Å3 Da−1, for a solvent content of 38%). In solving the holo-NadR structure, an initial
and marginal molecular replacement (MR) solution was obtained using as template search
model the crystal structure of the transcriptional regulator PA4135 (PBD entry 2FBI), with
which NadR shares ~54% sequence identity. This solution was combined with SAD data to aid
identification of two selenium sites in NadR, using autosol in phenix [38] and this allowed gener-
ation of high-quality electron density maps that were used to build and refine the structure of the
complex. Electron densities were clearly observed for almost the entire dimeric holo-NadR pro-
tein, except for a new N-terminal residues and residues 88–90 of chain B.
The crystal structure of apo-NadR was subsequently solved by MR in Phaser [39] at 2.7 Å,
using the final refined model of SeMet-NadR/4-HPA as the search model. For apo-NadR, elec-
tron densities were clearly observed for almost the entire protein, although residues 84–91 of
chains A, C, and D, and residues 84–90 of chain B lacked densities suggesting local disorder.
Both structures were refined and rebuilt using phenix [38] and Coot [40], and structural val-
idation was performed using Molprobity [41]. Data collection and refinement statistics are
reported in Table 2. Atomic coordinates of the two NadR structures have been deposited in the
Protein Data Bank, with entry codes 5aip (NadR bound to 4-HPA) and 5aiq (apo-NadR). All
crystallographic software was compiled, installed and maintained by SBGrid [42].
NMR spectroscopy
For heteronuclear NMR experiments, the NadR protein concentration used was 85 μM (~ 1.4
mg/mL) in a solution containing 100 mM sodium phosphate buffer (90%H2O and 10% D2O)
and 200 mMNaCl, prepared in the apo-form or in the presence of a 200-fold molar excess of
4-HPA, at pH 6.5. The stability, integrity and dimeric state of the protein in the NMR buffer was
confirmed by analytical SEC (Superdex 75, 10/300 column) prior to NMR studies. 1H-15N trans-
verse relaxation-optimized spectroscopy (TROSY)-heteronuclear single quantum coherence
(HSQC) experiments on apo-NadR and NadR in the presence of 4-HPA were acquired using an
Avance 950 Bruker spectrometer, operating at a proton frequency of 949.2 MHz and equipped
with triple resonance cryogenically-cooled probe at two different temperatures (298 K and 283
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K). 1H-15N TROSY-HSQC experiments were recorded for 12 h, with a data size of 1024 x 232
points. Spectra were processed using the Bruker TopSpin 2.1 and 3.1 software packages.
Western blot
Western blot analysis was performed as described previously [10].
Supporting Information
S1 Fig. Absolute molecular mass of NadR.Multi-angle laser light scattering (MALLS) analy-
ses were performed to determine the absolute molecular mass of NadR alone (A) or in the pres-
ence of 4-HPA ligand (B). The curves plotted correspond to Absorbance Units (mAU) at
280nm wavelength (green), light scattering (red), and refractive index (blue). The elution peak
maxima were at 17.5 minutes and the numerical data obtained for absolute molecular mass
and polydispersity are shown below each image. In both cases, the MALLS data clearly indi-
cated a single monodisperse species of absolute molecular mass ~ 37.5 kDa, corresponding to
the dimeric form of NadR. (The numbers ‘1’ at the bottom of the gradient-shaded slice identify
the beginning and end of each fraction-1, used for the MALLS analyses).
(TIF)
S2 Fig. Studies of the NadR-ligand interactions. Surface plasmon resonance (SPR) was used
to determine the equilibrium dissociation constants (KD), using the steady-state approach, for
the ligands 4-HPA (A), salicylate (B), 3Cl,4-HPA (C) and 3-HPA (D). SPR data are shown as
equilibrium binding response (RUeq) plotted against analyte (HPA) concentration (mM). Each
data point shown represents the mean RUeq value from three replicate experiments, as
described in the main textMaterials & Methods section. Rmax values for each curve are indi-
cated; n.d.: not determinable. The titrations included ligand concentrations from 10μM to
20mM. For 3-HPA and 4-HPA, all data points were used for curve-fitting; while for
3Cl,4-HPA, data points at analyte concentration> 4mM were excluded due to non-specific
association of the analyte on the sensor chip surface, possibly due to lower solubility of this
compound. As reported in the main text, the plot of equilibrium binding response (RUeq)
against analyte concentration enabled determination of the equilibrium binding constants
(KD) via the steady-state approach, and determination of Rmax enabled calculation of the bind-
ing stoichiometries (except for salicylate where Rmax could not be reliably determined).
(TIF)
S3 Fig. Conformational differences between apo- and holo-NadR structures. (A) ApoAB vs
Holo; (B) ApoAB vs ApoCD. For clarity, the comparisons are shown side-by-side with dimers
‘pulled apart horizontally’. The major rearrangement of the DNA-binding helix α4 observed
when comparing apo chain B (pale blue) and holo chain B (blue) (A, right) is concomitant
with notable changes (indicated by curvy arrows) in helices α1, α5, and α6, on both sides of the
dimer interface, which depart from an optimal structural alignment in both pairs of superposed
monomers. Instead, the two apo-homodimers mainly differ only in the orientation of the
region α2-α5 and only in their B chains (B, right), while the α6 helices at the dimer interface
were much less different (compare the alignments of helix α6 in A and B).
(TIF)
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